Index -
P/E 27.11
EPS (ttm) 3.09
Insider Own 17.20%
Shs Outstand 112.18M
Perf Week 38.91%
Market Cap 11.33B
Forward P/E 20.88
EPS next Y 4.02
Insider Trans -0.04%
Shs Float 111.82M
Perf Month 40.73%
Enterprise Value 11.06B
PEG 2.20
EPS next Q 1.05
Inst Own 85.73%
Short Float 5.66%
Perf Quarter 41.16%
Income 423.78M
P/S 4.09
EPS this Y 17.68%
Inst Trans 3.33%
Short Ratio 4.66
Perf Half Y 50.29%
Sales 2.77B
P/B 2.57
EPS next Y 8.75%
ROA 8.32%
Short Interest 6.33M
Perf YTD 1.43%
Book/sh 32.68
P/C 29.01
EPS next 5Y 12.33%
ROE 10.01%
52W High 94.93 -11.63%
Perf Year 10.99%
Cash/sh 2.89
P/FCF 19.55
EPS past 3/5Y -19.65% -13.26%
ROIC 9.41%
52W Low 51.79 61.98%
Perf 3Y 28.98%
Dividend Est. -
EV/EBITDA 15.26
Sales past 3/5Y 38.03% 26.25%
Gross Margin 61.05%
Volatility 3.60% 2.85%
Perf 5Y 58.10%
Dividend TTM -
EV/Sales 3.99
EPS Y/Y TTM 364.73%
Oper. Margin 16.21%
ATR (14) 3.15
Perf 10Y 275.35%
Dividend Ex-Date -
Quick Ratio 2.47
Sales Y/Y TTM 11.75%
Profit Margin 15.30%
RSI (14) 86.85
Recom 1.67
Dividend Gr. 3/5Y - -
Current Ratio 4.13
EPS Q/Q 134.07%
SMA20 35.05%
Beta 1.11
Target Price 90.00
Payout 0.00%
Debt/Eq 0.03
Sales Q/Q 22.91%
SMA50 40.27%
Rel Volume 9.17
Prev Close 61.71
Employees 5300
LT Debt/Eq 0.02
Earnings Nov 06 AMC
SMA200 27.75%
Avg Volume 1.36M
Price 83.89
IPO Aug 03, 2012
Option/Short Yes / Yes
EPS/Sales Surpr. 51.13% 4.68%
Trades
Volume 12,465,778
Change 35.94%
Date
Action
Analyst
Rating Change
Price Target Change
Nov-07-25 Upgrade
Truist
Hold → Buy
$93
Nov-07-25 Upgrade
BofA Securities
Neutral → Buy
$91
Oct-28-25 Resumed
Stifel
Hold
$64
May-27-25 Downgrade
BTIG Research
Buy → Neutral
Jan-10-25 Upgrade
BofA Securities
Underperform → Neutral
$97
Dec-02-24 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$83 → $100
Aug-07-24 Upgrade
Wells Fargo
Equal Weight → Overweight
$60 → $78
May-20-24 Upgrade
Piper Sandler
Neutral → Overweight
$60 → $80
Mar-18-24 Upgrade
BTIG Research
Neutral → Buy
$60
Oct-20-23 Initiated
ROTH MKM
Buy
$75
Sep-19-23 Upgrade
Stifel
Hold → Buy
$61
Mar-30-23 Upgrade
Canaccord Genuity
Hold → Buy
$67
Feb-13-23 Downgrade
BofA Securities
Buy → Underperform
$83 → $63
Feb-10-23 Downgrade
Wells Fargo
Overweight → Equal Weight
$67
Feb-10-23 Downgrade
Truist
Buy → Hold
$85 → $70
Feb-10-23 Downgrade
Needham
Buy → Hold
Feb-10-23 Downgrade
Loop Capital
Buy → Hold
$90 → $70
Feb-10-23 Downgrade
BTIG Research
Buy → Neutral
Oct-18-22 Initiated
Barclays
Overweight
$69
Oct-12-22 Initiated
Jefferies
Buy
$75
Show Previous Ratings
Nov-07-25 04:21PM
09:26AM
(Investor's Business Daily)
02:17PM
01:11PM
11:08AM
11:04AM
Loading…
11:04AM
09:26AM
06:36AM
Nov-06-25 07:30PM
06:55PM
05:55PM
(Associated Press Finance)
05:08PM
04:15PM
Nov-05-25 07:10PM
11:54AM
09:15AM
Loading…
09:15AM
Nov-04-25 10:12PM
06:20PM
08:39AM
08:39AM
08:38AM
Oct-31-25 10:15AM
Oct-30-25 10:00AM
Oct-29-25 09:40AM
Oct-28-25 05:15PM
09:16AM
Oct-24-25 09:00AM
Oct-23-25 07:53AM
Oct-17-25 09:08AM
Oct-16-25 04:30PM
04:40PM
Loading…
Oct-14-25 04:40PM
11:40AM
08:34AM
Oct-06-25 11:33PM
Oct-02-25 10:13AM
Oct-01-25 12:01AM
Sep-29-25 09:40AM
Sep-12-25 09:40AM
Sep-04-25 12:14PM
Sep-02-25 01:05AM
Aug-28-25 04:30PM
Aug-27-25 09:40AM
08:29AM
Aug-19-25 07:55AM
Aug-14-25 01:33AM
Aug-13-25 08:51AM
08:22AM
Aug-11-25 09:41AM
09:40AM
Aug-08-25 12:21PM
05:16AM
Aug-07-25 07:00PM
06:05PM
05:08PM
(Associated Press Finance)
04:15PM
Aug-06-25 09:15AM
07:10AM
Aug-05-25 11:11PM
Jul-31-25 10:00AM
Jul-28-25 11:11AM
Jul-25-25 08:40AM
Jul-22-25 06:00AM
Jul-21-25 12:21PM
08:30AM
08:00AM
Jul-18-25 01:11AM
Jul-17-25 04:30PM
10:38AM
Jul-16-25 09:04AM
Jul-15-25 04:15PM
10:06AM
Jul-11-25 12:38AM
Jul-01-25 08:10AM
Jun-30-25 08:50AM
Jun-18-25 12:05AM
Jun-11-25 11:34PM
Jun-10-25 08:40AM
Jun-05-25 09:37AM
May-27-25 01:52PM
May-15-25 04:30PM
May-12-25 07:24AM
May-09-25 08:22AM
(Thomson Reuters StreetEvents) -22.96%
03:39AM
May-08-25 06:30PM
05:45PM
04:43PM
(Associated Press Finance)
04:15PM
May-07-25 07:55PM
12:42PM
May-06-25 08:20AM
06:20AM
May-05-25 09:15AM
May-01-25 06:05PM
10:01AM
07:27AM
Apr-30-25 09:01AM
Apr-29-25 09:05AM
Apr-28-25 01:19PM
Apr-25-25 08:00AM
05:07AM
Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. It classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul, David D. Davidar and Andrew Iott in March 2003 and is headquartered in Audubon, PA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
RHOADS ANN D Director Nov 07 '25 Proposed Sale 80.96 8,000 647,681 Nov 07 12:17 PM RHOADS ANN D Director Sep 15 '25 Sale 58.46 10,000 584,600 25,384 Sep 16 05:16 PM RHOADS ANN D Director Sep 15 '25 Proposed Sale 58.40 10,000 584,000 Sep 15 03:51 PM RHOADS ANN D Director Feb 28 '25 Sale 78.68 7,500 590,100 35,384 Mar 04 04:38 PM RHOADS ANN D Director Feb 28 '25 Proposed Sale 78.67 7,500 590,000 Feb 28 11:05 AM Pfeil Keith W COO, CFO Jan 10 '25 Option Exercise 51.78 14,167 733,561 14,167 Jan 14 04:12 PM Pfeil Keith W COO, CFO Jan 10 '25 Sale 88.29 14,167 1,250,770 0 Jan 14 04:12 PM Pfeil Keith W Officer Jan 10 '25 Proposed Sale 88.29 14,167 1,250,772 Jan 10 11:20 AM Huller Kelly SVP, GC, Corporate Secretary Dec 02 '24 Option Exercise 24.21 2,500 60,525 2,500 Dec 04 04:12 PM Huller Kelly SVP, GC, Corporate Secretary Dec 02 '24 Sale 87.00 2,500 217,502 0 Dec 04 04:12 PM Huller Kelly Officer Dec 02 '24 Proposed Sale 86.95 2,500 217,364 Dec 02 04:35 PM Davidar David D Director Nov 21 '24 Sale 85.00 13,254 1,126,590 172,713 Nov 25 04:35 PM Davidar David D Director Nov 21 '24 Sale 85.00 13,234 1,124,890 523,041 Nov 25 04:35 PM Davidar David D Director Nov 22 '24 Sale 85.00 6,766 575,135 516,275 Nov 25 04:35 PM Davidar David D Director Nov 22 '24 Sale 85.00 6,746 573,435 165,967 Nov 25 04:35 PM Lemaitre Dan Director Nov 21 '24 Option Exercise 65.05 13,278 863,734 13,278 Nov 25 04:31 PM Lemaitre Dan Director Nov 22 '24 Option Exercise 65.05 1,097 71,360 1,097 Nov 25 04:31 PM Lemaitre Dan Director Nov 21 '24 Sale 85.00 13,278 1,128,630 0 Nov 25 04:31 PM Lemaitre Dan Director Nov 22 '24 Sale 85.02 1,097 93,263 0 Nov 25 04:31 PM Scavilla Daniel T President, CEO Nov 21 '24 Option Exercise 43.65 130,000 5,674,900 130,000 Nov 25 04:29 PM Scavilla Daniel T President, CEO Nov 21 '24 Sale 85.00 130,000 11,050,000 0 Nov 25 04:29 PM Davidar David D Director Nov 21 '24 Proposed Sale 85.00 20,000 1,700,000 Nov 21 07:12 PM Davidar David D Director Nov 21 '24 Proposed Sale 0.85 20,000 17,000 Nov 21 07:04 PM Davidar David D Director Nov 21 '24 Proposed Sale 84.95 3,500 297,311 Nov 21 06:54 PM Lemaitre Dan Director Nov 21 '24 Proposed Sale 85.00 14,375 1,221,875 Nov 21 06:05 PM Scavilla Daniel T Officer Nov 21 '24 Proposed Sale 84.95 130,000 11,043,000 Nov 21 04:31 PM Paul David C Executive Chairman Nov 15 '24 Option Exercise 24.10 26,042 627,612 26,042 Nov 20 04:15 PM